iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Holdings is supported by strong core business momentum, with 2Q revenue of $224 million up 20.1% year over year, a gross margin of 72.8%, and adjusted EBITDA of $43.3 million at a 19.3% margin, while management also raised FY26 revenue guidance to $880 million-$890 million and adjusted EBITDA margin guidance to 13%-14%. The company’s outlook is strengthened by multiple growth engines, including the innovative channel partner ramp to a mid-single-digit percentage of revenue, durable volume growth across cardiology and primary care, and a large runway in the PCP channel with more than 40,000 active prescribers out of roughly 500,000 addressable U.S. PCPs. Strategic optionality is further enhanced by the $287.5 million VitalConnect acquisition, which is expected to accelerate entry into the MCT market, complement Zio MCT still targeted for 1H27 approval, preserve 70%+ gross margin, and add more than $100 million of projected value from the Gen 3 algorithm over five years.

iRhythm Holdings is facing a fundamentally challenged setup because management’s broader growth thesis depends on executing a complex “toolbox” strategy across Zio A-T, Zio MCT, and VitalConnect while still resolving meaningful regulatory, legal, and operational overhangs that can distract from commercialization. Although the combined platform could improve its competitive position in the $1B MCT market and expand addressable opportunity by roughly 20% with Zio MCT while VitalConnect helps cover the remaining 30%, the company remains exposed to poor sales execution, increased competition, reimbursement pressure, sales force disruption, and a potential additional equity offering, all of which raise concern around durability of growth and profitability. The recent cyberattack, in which unauthorized access involved patient and proprietary data, and the ongoing DoJ investigation tied to Zio AT and a pre-warning-letter timeframe underscore execution and compliance risk, making the investment case dependent on several uncertainties resolving favorably rather than on clearly de-risked fundamentals.